| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |